Onconova Therapeutics, Inc. Up to $20,000,000 of Shares of Common Stock (par value $0.01 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • October 8th, 2014 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • New York
Onconova Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
